Specific amount of nightly sleep may lower diabetes risk, researchers find
A new study indicates that getting approximately seven hours and 18 minutes of sleep per night can lower the risk of diabetes by reducing insulin resistance.
A recent study conducted by a team of Chinese researchers highlights the importance of sleep duration in relation to insulin resistance, a significant risk factor for type 2 diabetes. The observational study, which spanned from 2009 to 2023 and included around 25,000 participants, identified that approximately seven hours and 18 minutes of sleep each night represented a 'sweet spot' for minimizing insulin resistance. Participants who veered away from this optimal sleep duration were found to have alterations in their metabolic markers that could contribute to an increased risk of diabetes.
The findings demonstrated a clear relationship between sleep patterns and insulin sensitivity, illuminating the detrimental effects of both insufficient and excessive sleep. Specifically, shorter sleep durations were correlated with elevated insulin resistance, suggesting that individuals getting less sleep may be at a higher risk for developing type 2 diabetes. Conversely, extending sleep beyond the established optimal duration led to unfavorable metabolic outcomes, indicating that over-sleeping can also contribute negatively to glucose metabolism.
Interestingly, the research further revealed that merely catching up on missed sleep during the weekends does not sufficiently counteract deficiencies accumulated throughout the week. The potential repercussions of excessive weekend sleep may exacerbate issues related to glucose metabolism, further underscoring the pivotal role of consistent, optimal sleep durations in overall metabolic health. This study serves as a call to action for individuals to prioritize balanced sleep routines as a strategic measure for diabetes prevention.